-
公开(公告)号:EP2903642A1
公开(公告)日:2015-08-12
申请号:EP13783724.1
申请日:2013-10-04
IPC分类号: A61K39/395 , C07K16/28
CPC分类号: C07K16/2878 , A61K2039/505 , C07K2317/74 , C07K2317/75
摘要: This disclosure describes methods that generally include administering to an immune compromised subject an amount of a lymphotoxin β receptor (LTβR) agonist effective to increase immune function in the subject compared to a suitable control immune compromised subject. In some cases, the method can result decreasing the period of immune deficiency in the subject compared to a suitable control immune compromised subject.